Literature DB >> 14988073

Regulation of alpha7-integrin expression in vascular smooth muscle by injury-induced atherosclerosis.

Jun-Tzu Chao1, Gerald A Meininger, Jan L Patterson, Sarah A L Jones, Charles R Partridge, Jessemy D Neiger, E Spencer Williams, Stephen J Kaufman, Kenneth S Ramos, Emily Wilson.   

Abstract

Injury of vascular smooth muscle cells (VSMCs) by allylamine (AAM) leads to phenotypic changes associated with atherogenic progression including increased proliferation, migration, and alterations in cell adhesion. In the present study, the relationship between AAM-induced vascular injury and expression of the alpha(7)-integrin subunit was investigated. The alpha(7)-mRNA and protein expression were examined using real-time RT-PCR, fluorescence-activated cell sorting analysis (FACS), immunohistochemistry, and immunoblotting. In cultured VSMCs from aortas of AAM-treated rats (70 mg/kg for 20 days), alpha(7)-mRNA levels were increased more than twofold compared with control cells. No change was seen in beta(1)-integrin expression. FACS analysis revealed increased cell surface expression of alpha(7)-protein (25 +/- 9%; *P < 0.05). AAM treatment of naive VSMCs enhanced alpha(7)-mRNA expression (2.4 +/- 0.7-fold, mean +/- SE; *P < 0.05). The increased alpha(7)-mRNA expression was attenuated by the amine oxidase inhibitor semicarbazide and the antioxidant pyrrolidine dithiocarbamate, which confirms a role for oxidative stress in modulating alpha(7)-expression. In vivo alpha(7)-mRNA and protein expression were enhanced in the aortas of AAM-treated rats. In addition, increased alpha(7)-integrin expression facilitated AAM VSMC adhesion to laminin more efficiently compared with control (51 +/- 2%; *P < 0.05). Chemical injury induced by AAM significantly enhances alpha(7)-integrin expression in VSMCs. These findings implicate for the first time the expression of alpha(7)-integrin during the response of VSMCs to vascular injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988073     DOI: 10.1152/ajpheart.00939.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  5 in total

1.  Placental defects in alpha7 integrin null mice.

Authors:  J V Welser; N D Lange; N Flintoff-Dye; H R Burkin; D J Burkin
Journal:  Placenta       Date:  2007-09-27       Impact factor: 3.481

2.  Laminin-binding integrin alpha7 is required for contractile phenotype expression by human airway myocytes.

Authors:  Thai Tran; Karen Ens-Blackie; Edward S Rector; Gerald L Stelmack; Karol D McNeill; Guido Tarone; William T Gerthoffer; Helmut Unruh; Andrew J Halayko
Journal:  Am J Respir Cell Mol Biol       Date:  2007-07-19       Impact factor: 6.914

Review 3.  Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2015-08-03       Impact factor: 4.774

4.  Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.

Authors:  Yang Zhou; Sudipta Chakraborty; Shuang Liu
Journal:  Theranostics       Date:  2011-01-18       Impact factor: 11.556

5.  Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells.

Authors:  Jiandong Zhang; Nancy A Noble; Wayne A Border; Rick T Owens; Yufeng Huang
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.900

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.